Northwest Biotherapeutics (NWBO) Short Interest Ratio & Short Volume $0.23 -0.01 (-3.16%) As of 03/31/2025 03:59 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestBuy This Stock Northwest Biotherapeutics Short Interest DataNorthwest Biotherapeutics (NWBO) has a short interest of 52.54 million shares, representing 4.25% of the float (the number of shares available for trading by the public). This marks a 3.30% increase in short interest from the previous month. The short interest ratio (days to cover) is 8.1, indicating that it would take 8.1 days of the average trading volume of 3.21 million shares to cover all short positions.Current Short Interest52,536,600 sharesPrevious Short Interest50,857,400 sharesChange Vs. Previous Month+3.30%Dollar Volume Sold Short$12.82 millionShort Interest Ratio8.1 Days to CoverLast Record DateMarch 15, 2025Outstanding Shares1,384,301,000 sharesShort Percent of Float4.25%Today's Trading Volume3,564,085 sharesAverage Trading Volume3,207,112 sharesToday's Volume Vs. Average111% Short Selling Northwest Biotherapeutics? Sign up to receive the latest short interest report for Northwest Biotherapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNWBO Short Interest Over TimeNWBO Days to Cover Over TimeNWBO Percentage of Float Shorted Over Time Remove Ads Northwest Biotherapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/202552,536,600 shares $12.82 million +3.3%4.2%8.1 $0.24 2/28/202550,857,400 shares $14.90 million +0.9%4.1%6.1 $0.29 2/15/202550,386,500 shares $12.40 million +4.4%4.1%8.2 $0.25 1/31/202548,267,700 shares $13.90 million +0.4%N/A6.7 $0.29 1/15/202548,101,600 shares $12.60 million +0.0%N/A9.5 $0.26 12/31/202448,095,200 shares $13.22 million +1.3%N/A6.9 $0.27 12/15/202447,487,000 shares $13.89 million +0.1%N/A9.8 $0.29 11/30/202447,424,300 shares $13.28 million -0.1%N/A11.8 $0.28 11/15/202447,475,500 shares $13.39 million +0.5%N/A10 $0.28 10/31/202447,248,100 shares $12.77 million -2.0%N/A13.6 $0.27 Get the Latest News and Ratings for NWBO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Northwest Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/15/202448,227,000 shares $13.79 million +2.1%N/A11.5 $0.29 9/30/202447,245,600 shares $15.12 million -2.0%N/A15.5 $0.32 9/15/202448,190,900 shares $15.81 million -4.4%N/A8.7 $0.33 8/31/202450,419,200 shares $15.62 million +0.3%N/A8.7 $0.31 8/15/202450,252,600 shares $17.39 million +3.7%N/A9.2 $0.35 7/31/202448,438,600 shares $17.05 million +0.3%N/A13.1 $0.35 7/15/202448,294,600 shares $18.85 million +1.4%N/A11.1 $0.39 6/30/202447,610,400 shares $20.32 million +0.5%N/A12.1 $0.43 6/15/202447,353,700 shares $20.46 million -14.0%N/A16.1 $0.43 5/31/202455,038,700 shares $24.89 million +6.0%N/A17.5 $0.45 5/15/202451,937,200 shares $25.42 million +5.4%N/A14.6 $0.49 4/30/202449,284,100 shares $22.92 million +3.3%N/A18.5 $0.47 4/15/202447,695,000 shares $23.94 million +4.0%N/A17 $0.50 3/31/202445,844,600 shares $23.79 million +0.8%N/A9.3 $0.52 3/15/202445,479,700 shares $23.97 million +0.5%N/A17.1 $0.53 2/29/202445,237,600 shares $24.83 million +0.8%N/A13.2 $0.55 2/15/202444,861,300 shares $25.08 million -1.5%N/A12.3 $0.56 1/15/202445,906,000 shares $29.27 million -0.5%N/A14 $0.64 12/31/202346,139,800 shares $32.34 million +0.8%N/A11.1 $0.70 12/15/202345,776,800 shares $33.87 million -1.9%N/A19.9 $0.74 11/30/202346,647,900 shares $35.45 million -5.3%N/A15.3 $0.76 11/15/202349,260,600 shares $41.50 million -11.6%N/A10.1 $0.84 10/31/202355,750,400 shares $42.93 million +2.8%N/A18.6 $0.77 10/15/202354,229,800 shares $37.36 million +3.6%N/A12.2 $0.69 9/30/202352,330,400 shares $47.60 million +2.7%N/A5.3 $0.91 9/15/202350,976,500 shares $35.00 million +4.2%N/A12.1 $0.69 8/31/202348,940,600 shares $28.15 million +3.1%N/A8.8 $0.58 8/15/202347,481,100 shares $23.42 million +5.5%N/A15.5 $0.49 7/31/202344,998,100 shares $23.83 million +1.6%N/A16.9 $0.53 7/15/202344,299,500 shares $24.67 million +2.3%N/A18.4 $0.56Trump’s Secret Weapon (Ad)Have you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next. But here's the truth… This is just the beginning. Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better. Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times. Don't wait for the next crash to wipe you out. Act now.Get Your FREE Presidential Transition Guide Today 6/30/202343,316,900 shares $24.60 million +3.2%N/A17.2 $0.57 6/15/202341,973,700 shares $27.29 million +3.0%N/A10.9 $0.65 5/31/202340,738,000 shares $24.44 million +2.2%N/A18.7 $0.60 5/15/202339,849,500 shares $24.49 million +6.5%N/A12.7 $0.61 4/30/202337,419,400 shares $18.71 million -4.7%N/A8.9 $0.50 4/15/202339,268,700 shares $21.05 million +0.3%N/A12 $0.54 3/31/202339,133,700 shares $24.46 million -0.3%N/A10 $0.63 3/15/202339,268,200 shares $22.97 million -2.2%N/A15.8 $0.59 2/28/202340,154,000 shares $26.30 million +2.8%N/A14.6 $0.66 2/15/202339,064,000 shares $26.76 million +0.9%N/A9.4 $0.69 1/31/202338,719,500 shares $27.34 million -6.3%N/A12.7 $0.71 1/15/202341,300,600 shares $30.15 million -1.4%N/A9.5 $0.73 12/30/202241,886,300 shares $32.86 million +0.3%N/A11.1 $0.78 12/15/202241,783,300 shares $37.02 million +8.3%N/A6.9 $0.89 11/30/202238,579,900 shares $32.37 million +40.5%N/A2.9 $0.84 11/15/202227,453,900 shares $25.88 million +0.4%N/A5.8 $0.94 10/31/202227,335,600 shares $20.67 million -0.7%N/A11.8 $0.76 10/15/202227,532,400 shares $18.56 million -1.7%N/A13.6 $0.67 9/30/202228,010,900 shares $20.00 million -3.6%N/A12.2 $0.71 9/15/202229,057,900 shares $21.65 million -4.7%N/A9.1 $0.75 8/31/202230,503,400 shares $21.20 million -2.9%N/A7.8 $0.70 8/15/202231,424,300 shares $19.58 million -1.2%N/A12.1 $0.62 7/31/202231,803,000 shares $22.34 million +1.8%N/A11.5 $0.70 7/15/202231,231,700 shares $21.51 million -5.0%N/A8.6 $0.69 6/30/202232,876,700 shares $20.71 million -2.1%N/A13.9 $0.63 6/15/202233,595,700 shares $21.65 million +5.9%N/A7.9 $0.64 5/31/202231,736,000 shares $22.06 million +9.3%N/A3.9 $0.70 5/15/202229,024,800 shares $23.51 million -2.0%N/A0.9 $0.81 4/30/202229,604,500 shares $31.38 million +2.9%N/A9.8 $1.06 4/15/202228,766,900 shares $27.01 million +12.1%N/A7 $0.94 3/31/202225,661,400 shares $17.89 million +5.3%N/A13 $0.70 3/15/202224,381,800 shares $16.99 million +10.6%N/A7.2 $0.70 2/28/202222,051,000 shares $20.07 million +9.9%N/A10.3 $0.91 2/15/202220,060,200 shares $18.70 million +4.9%N/A8.3 $0.93 1/31/202219,127,700 shares $17.02 million +7.7%N/A5.3 $0.89 1/15/202217,767,800 shares $14.57 million +9.8%N/A4.5 $0.82 12/31/202116,182,000 shares $11.33 million +3.7%N/A3.2 $0.70 12/15/202115,605,200 shares $10.30 million +17.5%N/A2.5 $0.66 11/30/202113,284,900 shares $11.31 million +10.3%N/A1.8 $0.85 11/15/202112,050,200 shares $12.65 million -4.0%N/A3.4 $1.05 10/29/202112,555,100 shares $13.69 million +10.3%N/A2.5 $1.09 10/15/202111,381,500 shares $13.43 million -0.3%N/A4.3 $1.18 9/30/202111,412,800 shares $14.61 million -0.5%N/A3.9 $1.28 9/15/202111,466,300 shares $14.10 million +1.9%N/A5.9 $1.23 8/31/202111,253,800 shares $14.74 million -7.0%N/A6.1 $1.31 8/13/202112,102,000 shares $14.76 million -2.3%N/A3.5 $1.22 7/30/202112,385,100 shares $14.79 million +0.6%N/A4.5 $1.19 7/15/202112,311,000 shares $15.63 million -35.6%N/A4.3 $1.27 6/30/202119,124,000 shares $28.11 million -0.2%N/A7.2 $1.47 6/15/202119,170,000 shares $29.71 million -3.9%N/A5.9 $1.55Trump’s Secret Weapon (Ad)Have you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next. But here's the truth… This is just the beginning. Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better. Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times. Don't wait for the next crash to wipe you out. Act now.Get Your FREE Presidential Transition Guide Today 5/28/202119,937,300 shares $33.30 million +0.7%N/A3.8 $1.67 5/14/202119,792,900 shares $29.59 million +3.0%N/A9 $1.50 4/30/202119,211,900 shares $28.05 million +1.2%N/A6.6 $1.46 4/15/202118,982,800 shares $25.91 million +13.3%N/A6.6 $1.37 3/31/202116,756,000 shares $25.13 million +2.1%N/A5.1 $1.50 3/15/202116,407,600 shares $24.85 million +2.4%N/A6.2 $1.51 2/26/202116,016,700 shares $24.03 million +2.0%N/A3.8 $1.50 2/12/202115,710,400 shares $24.98 million -3.8%N/A4.1 $1.59 1/29/202116,322,900 shares $25.95 million +5.7%N/A3.9 $1.59 1/15/202118,463,500 shares $24.28 million -10.9%N/A4.3 $1.32 12/31/202014,905,500 shares $22.66 million -19.3%N/A2.4 $1.52 12/15/202018,463,500 shares $24.00 million -10.9%N/A4.3 $1.30 11/30/202020,732,200 shares $25.29 million +0.2%N/A6.5 $1.22 11/15/202020,695,300 shares $28.15 million +11.0%N/A2.4 $1.36 10/30/202018,648,000 shares $22.19 million +3.5%N/A0.6 $1.19 10/15/202018,018,300 shares $19.10 million -1.2%N/A1.9 $1.06 9/30/202018,230,900 shares $14.06 million +9.9%N/A1.3 $0.77 9/15/202016,592,800 shares $11.67 million +25.1%N/A0.9 $0.70 8/31/202013,263,500 shares $4.64 million +10.0%N/A4.2 $0.35 8/14/202012,060,300 shares $3.91 million +9.2%N/A2.7 $0.32 7/31/202011,047,400 shares $3.92 million -5.1%N/A1.8 $0.35 7/15/202011,636,600 shares $4.04 million +3.5%N/A5 $0.35 6/30/202011,240,500 shares $3.86 million +4.8%N/A4 $0.34 6/15/202010,723,000 shares $3.76 million +24.0%N/A2.2 $0.35 5/29/20208,644,800 shares $3.00 million +47.4%N/A0.9 $0.35 5/15/20205,865,200 shares $973,623.20 +2.4%N/A2.9 $0.17 4/30/20205,725,500 shares $983,068.35 -1.0%N/A1.6 $0.17 4/15/20205,782,700 shares $1.01 million +0.9%N/A1.7 $0.17 NWBO Short Interest - Frequently Asked Questions What is Northwest Biotherapeutics' current short interest? Short interest is the volume of Northwest Biotherapeutics shares that have been sold short but have not yet been closed out or covered. As of March 15th, investors have sold 52,536,600 shares of NWBO short. 4.25% of Northwest Biotherapeutics' shares are currently sold short. Learn More on Northwest Biotherapeutics' current short interest. What is a good short interest ratio for Northwest Biotherapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NWBO shares currently have a short interest ratio of 8.0. Learn More on Northwest Biotherapeutics's short interest ratio. What is a good short interest percentage for Northwest Biotherapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.25% of Northwest Biotherapeutics' floating shares are currently sold short. Is Northwest Biotherapeutics' short interest increasing or decreasing? Northwest Biotherapeutics saw a increase in short interest in March. As of March 15th, there was short interest totaling 52,536,600 shares, an increase of 3.3% from the previous total of 50,857,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Northwest Biotherapeutics' short interest compare to its competitors? 4.25% of Northwest Biotherapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Northwest Biotherapeutics: Adaptive Biotechnologies Co. (6.86%), ARS Pharmaceuticals, Inc. (37.52%), Ardelyx, Inc. (13.62%), Evotec SE (0.21%), Ocular Therapeutix, Inc. (8.46%), Structure Therapeutics Inc. (12.92%), Iovance Biotherapeutics, Inc. (25.34%), Syndax Pharmaceuticals, Inc. (22.99%), Aurinia Pharmaceuticals Inc. (9.37%), Spyre Therapeutics, Inc. (21.06%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks. What does it mean to sell short Northwest Biotherapeutics stock? Short selling NWBO is an investing strategy that aims to generate trading profit from Northwest Biotherapeutics as its price is falling. NWBO shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Northwest Biotherapeutics? A short squeeze for Northwest Biotherapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NWBO, which in turn drives the price of the stock up even further. How often is Northwest Biotherapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NWBO, twice per month. The most recent reporting period available is March, 15 2025. More Short Interest Resources from MarketBeat Related Companies ADPT Short Interest Data SPRY Short Interest Data ARDX Short Interest Data EVO Short Interest Data OCUL Short Interest Data GPCR Short Interest Data IOVA Short Interest Data SNDX Short Interest Data AUPH Short Interest Data SYRE Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:NWBO) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | SponsoredTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredIs Fort Knox Hiding Less Gold Than We Think? Find Out What That Means for YouWith gold prices recently soaring to record highs over $3,000 an ounce, and central banks rushing to accumulat...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Northwest Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Northwest Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
